[Form 4] FULLER H B CO Insider Trading Activity

Rhea-AI Filing Summary

Fuller H. B. Co. (FUL) Form 4: John J. Corkrean, Executive Vice President and CFO, reported insider activity dated 09/26/2025. The filing shows a disposition of 52,196 shares of common stock reported in Table I. Table II records derivative and equity-based holdings: acquisition of 162.12 phantom units that convert 1-for-1 into common stock, and a schedule of existing employee stock options and restricted stock units that the reporting person beneficially owns following the transactions (optioned shares range from 16,672 to 48,309 per grant; multiple RSU grants totaling 1,297.11, 2,841.16 and 4,352.99 shares). The form is signed by an attorney-in-fact on 09/29/2025. The filing documents routine exercised/vested equity awards and a reported share sale; no earnings or forward-looking guidance is included.

Insights

Financial Analyst

TL;DR: Insider sold a significant block of shares while retaining substantial option and RSU holdings.

The 52,196-share disposition is a notable, discrete sale that reduces direct common stock holdings but the reporting person continues to hold extensive equity exposure via vested stock options and RSUs. The acquisition of 162.12 phantom units (convertible 1-for-1) modestly increases deferred equity exposure. These movements appear consistent with compensation realization and routine liquidity events rather than a change in control or company fundamentals, as the filing contains no operational or financial statements.

Corporate Governance Expert

TL;DR: Transaction documentation is standard and properly disclosed under Section 16 reporting.

The Form 4 lists the reporting person’s role (Executive VP & CFO) and discloses both non-derivative disposition and multiple derivative/award positions with vesting schedules noted. The filing includes the attorney-in-fact signature and explanatory footnotes on conversion and dividend-equivalent features, indicating appropriate disclosure practices. No material governance or compliance concerns are present in the disclosed items.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Corkrean John J

(Last) (First) (Middle)

1200 WILLOW LAKE BOULEVARD

P.O. BOX 64683

(Street)

ST. PAUL MN 55164-0683

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
FULLER H B CO [ FUL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive VP and CFO

3. Date of Earliest Transaction (Month/Day/Year)
09/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								52,196	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Units	$0.0000(1)	09/26/2025		A		162.12		(2)	(2)	Common Stock	162.12	$58.14	26,771.73(3)	D
Employee Stock Option (Right-to-Buy)	$43.48							05/17/2017(4)	05/17/2026	Common Stock	16,672		16,672	D
Employee Stock Option (Right-to-Buy)	$45.05							01/24/2020(4)	01/24/2029	Common Stock	41,208		41,208	D
Employee Stock Option (Right-to-Buy)	$48.35							01/24/2021(4)	01/24/2030	Common Stock	48,309		48,309	D
Employee Stock Option (Right-to-Buy)	$50.1							01/26/2018(4)	01/26/2027	Common Stock	23,696		23,696	D
Employee Stock Option (Right-to-Buy)	$51.89							01/27/2022(4)	01/27/2031	Common Stock	38,376		38,376	D
Employee Stock Option (Right-to-Buy)	$53.57							01/25/2019(4)	01/25/2028	Common Stock	21,834		21,834	D
Employee Stock Option (Right-to-Buy)	$64.28							01/27/2026(5)	01/27/2035	Common Stock	24,570		24,570	D
Employee Stock Option (Right-to-Buy)	$68.17							01/24/2024(5)	01/24/2033	Common Stock	22,312		22,312	D
Employee Stock Option (Right-to-Buy)	$72.94							01/24/2023(4)	01/24/2032	Common Stock	21,997		21,997	D
Employee Stock Option (Right-to-Buy)	$77.72							01/26/2025(5)	01/26/2034	Common Stock	24,774		24,774	D
Restricted Stock Units	$0.0000(6)							01/24/2024(7)	01/24/2026	Common Stock	1,297.11		1,297.11(8)	D
Restricted Stock Units	$0.0000(6)							01/26/2025(7)	01/26/2027	Common Stock	2,841.16		2,841.16(8)	D
Restricted Stock Units	$0.0000(6)							01/27/2026(7)	01/27/2028	Common Stock	4,352.99		4,352.99(8)	D

Explanation of Responses:

1. These units (acquired after 12-31-04) convert into shares of common stock on a 1-for-1 basis.

2. These units (acquired after 12-31-04) convert into shares of common stock upon the earlier of certain termination events as specified in the Key Employee Deferred Compensation Plan or such earlier date as selected by the participant, subject to holding periods required by law.

3. Amount includes stock units acquired pursuant to a dividend equivalent feature.

4. This option is 100% vested.

5. This option vests in three annual installments (33%, 33%, and 34%) beginning on the date shown.

6. These restricted stock units convert into shares of common stock on a 1-for-1 basis.

7. These restricted stock units vest in three annual installments (33%, 33%, and 34%) beginning on the date shown.

8. Amount includes restricted stock units acquired pursuant to a dividend equivalent reinvestment feature.

	/s/ Patrick J. Seul, Attorney-in-Fact	09/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did John J. Corkrean (FUL) report on the Form 4?

The Form 4 reports a disposition of 52,196 common shares on 09/26/2025 and the acquisition of 162.12 phantom units convertible 1-for-1 into common stock.

Does the filing show any newly exercisable stock options for the reporting person?

The filing lists multiple employee stock options with various exercise prices and vesting/expiration dates; several grants are listed as fully vested and are held following the reported transactions (for example, 16,672; 41,208; 48,309 shares per listed grants).

Are there restricted stock units (RSUs) disclosed in the Form 4 for FUL?

Yes. The filing shows RSU grants that convert 1-for-1 to common stock and vest in scheduled installments, including amounts of 1,297.11; 2,841.16; and 4,352.99 shares.

When was the Form 4 signed and by whom?

The Form 4 bears an attorney-in-fact signature (/s/ Patrick J. Seul) dated 09/29/2025.

Does the Form 4 include any earnings, guidance, or indications of a change in control?

No. The filing contains only insider ownership and transaction disclosures; it does not include earnings, guidance, or statements about corporate control.